Pycnogenol

Quick links to important sections

Pycnogenol

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Pycnogenol

Pycnogenol: A Standardized Botanical Extract and Phytotherapy Agent

Property Description
Active Ingredient Oligomeric Proanthocyanidins (OPCs) / Procyanidins
Form Capsules, tablets, fine powder, topical preparations
Pharmacological Class Nutraceutical, Antioxidant, Vasoactive Agent
General Purpose Supports cardiovascular function and cellular integrity
Origin Bark of the French Maritime Pine (Pinus pinaster Aiton)

Pycnogenol® is a proprietary standardized extract derived exclusively from the inner bark of the French maritime pine (Pinus pinaster Aiton), classifying it as a nutraceutical and dietary supplement within the field of phytotherapy. Originating from the coastal southwest of France, this pure, plant-based extract is used as an over-the-counter (OTC) product. The extract's primary function is acting as a potent antioxidant, which helps neutralize cellular stress. Pycnogenol® complies with the quality specifications outlined in the United States Pharmacopeia (USP) monograph for "Pine extract".

What is Pycnogenol Made Of? The Role of Procyanidins and Polyphenols

The extract's chemical activity is attributed to its complex profile of phenolic compounds, primarily Oligomeric Proanthocyanidins (OPCs), which are standardized and collectively known as procyanidins. Pycnogenol® is defined by its rigorous standardization, ensuring a consistent concentration of procyanidins across batches, which is a key differentiator from generic pine bark products. The extract is characterized as a vasoactive agent with effects on the endothelium, supporting the structural and functional integrity of blood vessels. The substance also contains various low-molecular-weight bioflavonoids and organic acids, including catechin, epicatechin, and taxifolin, which collectively enhance its biological activity.

High-Level Purpose: Supporting Wellness through Antioxidant and Vasoactive Action

Pycnogenol®'s general purpose is to promote systemic health and cellular integrity through its multimodal action, fitting the high-level pharmacological class of an antioxidant and vasoactive agent. This effect is achieved through its primary actions, which involve free radical neutralization and support for endothelial function by helping to modulate the production of nitric oxide (NO). In the context of maintaining vascular function, these combined effects contribute to the maintenance of blood flow and overall cardiovascular health in adults seeking nutritional support.

Regulatory References

  1. USP Monograph for "Pine extract"

What side effects are possible with Pycnogenol?

Possible Side Effects and Safety Information

Official safety documentation establishes that adverse reactions associated with Pycnogenol are generally reported with a very low frequency rate in clinical studies. The safety profile is defined by non-serious, reversible effects, primarily affecting specific physiological systems.

System-Organ Class Officially Documented Adverse Reactions
Gastrointestinal System Stomach pain, gastric discomfort, nausea, diarrhea
Nervous System Headache, dizziness
Dermatological System Urticaria (hives)

Gastrointestinal discomfort is noted as the most frequently observed adverse event, often managed by ensuring the extract is taken with food, as noted in high-level safety reports. No serious adverse events (SAEs) have been officially documented in clinical trials or through post-marketing surveillance, confirming the generally favorable safety classification of the substance.

Specific Safety Constraints and Precautions

The official safety information includes several population-specific and procedure-related constraints. Use is generally not recommended for children younger than 6 years old, and caution is advised during the first three months of pregnancy and while breastfeeding, due to a lack of established safety data in these groups. Furthermore, regulatory notes indicate that the substance may possess properties that slow blood clotting. Therefore, caution is warranted for individuals with existing bleeding conditions, and temporary cessation is typically advised for at least two weeks prior to any scheduled surgical procedures.

Overdose and Emergency Response

The official regulatory documents for Pycnogenol, a widely studied nutraceutical, do not define a specific toxicological overdose syndrome. The substance's high safety profile means that a high threshold for adverse events is generally observed; however, cases of excessive consumption have been formally associated with severe physiological findings.

Officially Documented Manifestations and Severe Outcomes

Excessive Pycnogenol consumption has been linked in government-cited reports to severe rhabdomyolysis, a condition characterized by diffuse myalgia and markedly elevated creatine kinase (CK) levels. This acute change carries the risk of serious complications, including acute kidney injury (AKI). Less severe presentations arising from high intake include mild, self-limiting adverse events, such as gastrointestinal discomfort, headache, or dizziness.

Emergency Action and Required Management

Urgent medical attention is required upon the manifestation of severe symptoms, including unusual muscle pain, dark-colored urine (potential signs of rhabdomyolysis), or a severe hypersensitivity reaction (e.g., shortness of breath or hives). This constitutes the specific trigger for emergency action as stated in regulatory safety profiles. The documented clinical approach for managing high-dose exposure is to administer symptomatic and supportive treatment. Official regulatory records indicate that no specific antidote for Pycnogenol is known.

Therapeutic Uses of Pycnogenol

What Pycnogenol Treats: Main Uses and Benefits

Pycnogenol is applied across domains where additional symptomatic support is needed, addressing symptom clusters that may become intense or disruptive. It may be part of symptomatic management to support patients during difficult episodes by easing distress. Relevant when supportive symptom management is appropriate, Pycnogenol is subject to investigation across multiple therapeutic areas.

The therapeutic benefit is commonly used to help with symptoms related to venous insufficiency, joint discomfort associated with Osteoarthritis, seasonal and respiratory manifestations, and menopausal discomforts. The extract is commonly used to help with acute or recurrent episodes where heightened symptoms interfere with daily stability.

“It is used in clinical settings that involve acute or unstable symptom patterns, contributing to the easing of the overall symptom load.”

Relief for Leg Discomfort and Circulatory Symptoms

Pycnogenol is commonly used across conditions presenting with acute episodes related to compromised microcirculation. It is relevant for easing challenging symptoms like leg heaviness, aching, and swelling (edema). The therapeutic benefit contributes to easing the overall symptom load and may assist with maintaining functional stability during phases of heightened circulatory discomfort.

Support for Joint and Musculoskeletal Comfort

It is relevant in contexts marked by increased discomfort or tension in the joints. Pycnogenol may assist with managing symptoms related to inflammatory or irritative states, such as the pain and stiffness. This use provides support that helps ease the overall symptom burden and may assist with maintaining functional stability when joint discomfort becomes more noticeable.

Quick Fact: Supports Symptomatic Management for Joint and Circulatory Axes

Eligibility and Restrictions for Use

Official Eligibility and Restrictions

The eligibility for Pycnogenol is governed by regulatory summaries that establish absolute prohibitions and conditional restrictions, primarily based on data sufficiency and potential physiological effects. Use is considered established for adults and older adults without underlying contraindications.

Populations Excluded or Restricted

Status Population Group Regulatory Basis
Contraindicated Individuals with a documented allergy or known hypersensitivity to the maritime pine extract or any of the product's components. Absolute regulatory prohibition.
Not Recommended Children under 6 years of age. Precaution due to insufficient confirmed dosing and safety data in this age group.
Not Recommended Pregnant individuals (first trimester) and breastfeeding mothers. Precaution based on a lack of reliable data during early gestation and lactation.

Conditional Use and Required Caution

Conditional use or required caution applies to individuals with specific health conditions due to the theoretical potential for the extract to affect key physiological processes:

  • Bleeding Conditions: Caution is necessary as the substance might affect blood clotting.
  • Diabetes: Caution is necessary as the substance might influence blood sugar levels.
  • Autoimmune Conditions: Caution is advised due to the potential for the substance to influence immune activity.
  • Pre-Surgical Patients: Use must be discontinued at least two weeks before any scheduled procedure due to the risk of affecting blood coagulation.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Pycnogenol's interaction profile is primarily defined by its documented pharmacodynamic additive effects across several physiological systems, as detailed in government safety summaries and monographs. The product is not formally cited with specific metabolic or transporter-mediated (CYP- or P-gp) interactions in regulatory labeling.

Documented Pharmacodynamic Interaction Classes

The co-administration of Pycnogenol with certain therapeutic agents may lead to an increased effect, classified as a clinically significant additive interaction risk by health authorities:

  • Anti-coagulant and Anti-platelet Agents: Co-administration may result in additive effects on blood clotting, raising the potential for bruising and bleeding (e.g., Warfarin, Aspirin).
  • Antidiabetes Drugs: Additive effects on systemic glucose levels may increase the risk of hypoglycemia.
  • Antihypertensive Agents: Additive effects on blood pressure may increase the potential for hypotension.
  • Immunosuppressants: Co-administration may decrease the intended efficacy of these medicines due to the supplement's effects on immune system activity.

Interaction-Related Restrictions

Official regulatory guidance mandates a specific administrative timing restriction: Pycnogenol should be discontinued at least two weeks prior to any scheduled surgical procedure due to its potential effects on blood clotting. Furthermore, caution is advised regarding its co-administration with herbal products or supplements (e.g., Garlic, Ginkgo biloba) that exhibit anti-platelet or anti-coagulant effects, as this may compound the bleeding risk.

Mechanism of Action

The physiological actions of Pycnogenol are driven by the multi-modal activity of its constituent Oligomeric Proanthocyanidins (OPCs), which engage three core mechanistic domains and modulate defined physiological pathways.

Modulation of Vascular Endothelial Function

The extract's compounds interact with the lining of blood vessels to enhance the activity of the enzyme eNOS (Endothelial Nitric Oxide Synthase). This action increases the generation and bioavailability of Nitric Oxide (NO), a signaling molecule that modulates vascular tone. The resulting physiological change is the relaxation of vascular smooth muscle and the adjustment of microcirculatory flow dynamics.

Intervention in Key Inflammatory Cascades

Pycnogenol works by inhibiting the activation of the central transcriptional regulator NF-κB (Nuclear factor kappa B). This molecular intervention suppresses the gene expression of pro-inflammatory enzymes like COX-2 and 5-LOX, which in turn reduces the cellular synthesis of mediators such as prostaglandins and leukotrienes. This mechanism results in the reduction of signaling within the inflammatory pathway.

Neutralization of Systemic Oxidative Stress

The OPCs function as chemical antioxidants that directly neutralize harmful Free Radicals (Reactive Oxygen Species/ROS). This scavenging action preserves the integrity of lipids and proteins, particularly within the sensitive vascular endothelium. This effect reduces the impact of systemic oxidative damage on cellular structures.

Dosage and Administration Information

The administration of Pycnogenol is defined by specific routes, standardized dose ranges, and consistent timing patterns, aligning with its status as a recognized nutraceutical extract.

Official Administration and Dosing

The most common route of administration for systemic use is oral, typically via capsules or tablets, although topical preparations are also utilized for local application. The registered homeopathic liquid formulation is administered as oral drops.

Standard dosing for the standardized extract generally falls within the range of 30 mg to 200 mg daily for adult use. A higher dose, up to 360 mg daily, has been utilized for short, initial periods of use, which is typically followed by a lower maintenance dose.

Frequency and Contextual Use

Administration frequency for the standardized extract is characterized by divided use, meaning the total daily dose is split and taken two or three times over the course of the day. A key instruction is the co-administration with food, as the oral formulation is generally instructed to be taken with or after a meal.

Usage patterns are observed for both short-term courses, sometimes for periods up to three months, and as part of long-term maintenance plans. Specific guidance for pediatric use references weight-based dosing, often 1 mg per kg of body weight daily. This framework establishes the necessary procedural steps for the proper intake of the product.

Recent Clinical Evidence

Research evidence / Overview of Studies for Pycnogenol

Evidence for Use in Supporting Healthy Blood Circulation and Venous Function

Research was studied for conditions characterized by fluctuating or episodic manifestations related to compromised microcirculation. The research examined patient-reported outcomes related to common symptoms, such as leg heaviness, aching, and swelling (edema). These trials are relevant in trials assessing short-term or episodic symptom patterns where blood flow and comfort can vary.

Studies report measurements of change in these observed outcomes related to physical discomfort across the study duration. Research data show patterns related to the overall symptom load and functional stability in the observed populations, particularly during periods of increased symptom activity. The findings help contextualize how patients reported their experience with these symptoms over the defined time intervals.

Evidence for Use in Managing Joint Discomfort and Maintaining Musculoskeletal Function

Research was evaluated in individuals with conditions characterized by fluctuating or episodic manifestations in the joints, such as those associated with Osteoarthritis. The studies examined how symptoms of pain and stiffness were measured in these populations. They also explored outcomes reflecting daily functioning or activity level to provide context on the overall symptom burden.

Evidence for Use in Supporting Overall Cardiovascular and Endothelial Health

Pycnogenol was observed in adult populations where research examined outcomes related to systemic or functional imbalance in the vascular system. These studies explored parameters of endothelial function and measured changes in blood flow and overall vascular function.

Key Uncertainties and Areas for Future Research

The evidence highlights what is known—and what is still uncertain. Evidence quality varies across studies, and some research shows that sample sizes were modest, contributing to uncertainty. Furthermore, the reliance on follow-up durations that were limited means that long-term effects are not fully established. More research is needed to provide greater certainty regarding long-term outcomes and to better characterize the findings across a wider range of populations and study designs.

Frequently Asked Questions (FAQ)

Common questions about Pycnogenol (FAQ)

Q: Does Pycnogenol contain caffeine?

Official product labeling, which defines the composition of the Pycnogenol extract, confirms its origin as maritime pine bark. According to regulatory standards and the official United States Pharmacopeia (USP) Monograph, caffeine is not listed as an active or primary component of the standardized extract.

Q: How quickly does Pycnogenol start working for general support?

Studies on the product’s absorption indicate that its low-molecular-weight components are rapidly absorbed into the bloodstream within a few hours. However, observed outcomes in clinical trials related to general health support have often been measured after weeks or months of consistent use.

Q: Have there been large-scale clinical trials on Pycnogenol?

Safety data for Pycnogenol is derived from numerous investigations that have collectively involved thousands of subjects over time. While official reviews sometimes note that the sample sizes of specific individual efficacy studies have been modest, the body of evidence has been used to establish a safety profile and define areas of research interest.

Q: Where can I find unbiased information about Pycnogenol research results?

Authoritative and unbiased information regarding Pycnogenol research is available to the public through official government-run sources. You can find summaries and listings of clinical trials by searching databases such as NIH MedlinePlus, ClinicalTrials.gov, and PubMed Central (PMC).

Q: Is there a maximum time frame for taking Pycnogenol mentioned in studies?

Official documentation and research literature do not specify a hard limitation or maximum duration for the use of Pycnogenol. Clinical data reflects diverse usage patterns, documenting both short-term courses lasting a few weeks and long-term maintenance plans extending for a year or more.

Q: Does the time of day matter when taking Pycnogenol?

Official guidance primarily emphasizes that the product should be taken with or immediately after a meal. This practice is suggested in documentation to help address the most common mild adverse reaction, which is gastrointestinal discomfort. Regulatory information does not specify a difference in benefit between morning or evening intake.

Q: Does Pycnogenol affect energy levels?

Pycnogenol's official side effect profile lists minor effects such as headache and dizziness. Although some clinical research has examined the extract's role in physical performance in athletes, consistent evidence regarding a direct, general effect on energy is not generally noted in official reports.

Q: Why do some sources claim Pycnogenol helps with skin appearance?

While skin appearance is not listed as a primary health purpose, clinical research has explored this area. These studies have investigated the extract's effects on several factors related to skin health, including skin elasticity, hydration levels, and parameters associated with defense against UV exposure.

Q: Does Pycnogenol have any known effects on sleep patterns?

The official side effects profile for Pycnogenol does not include common sleep disturbances like insomnia or excessive drowsiness. Regulatory safety documentation contains no consistent clinical evidence to suggest a direct or significant impact on general sleep patterns.

Q: Can Pycnogenol be used by people with specific dietary restrictions (e.g., vegan, gluten-free)?

The Pycnogenol extract itself is derived exclusively from the French maritime pine bark, making the core ingredient plant-based. The status of the final product as vegan or gluten-free, however, is determined by reviewing the individual product's label for the specific excipients (inactive ingredients) used in commercial formulations.

Q: What should a person do if they suspect a mild reaction to Pycnogenol?

Official safety documentation notes that any severe allergic reaction, such as difficulty breathing or severe hives, warrants seeking immediate medical attention. For mild reactions, such as gastrointestinal discomfort, documentation indicates that co-administration with food is a common method discussed to help mitigate symptoms.

Q: Are there specific food or beverage items that interact with Pycnogenol?

Regulatory safety documents detail known interactions with certain categories of medications and herbal supplements. However, these documents do not specifically list common foods or non-herbal beverages, such as fruit juice or alcohol, as items that interact with the product.

Q: What does the research say about Pycnogenol and eye health?

Clinical research has been conducted to investigate Pycnogenol's supportive role in eye health. These studies specifically focus on managing conditions that involve the small blood vessels of the retina, such as those associated with diabetic retinopathy.

Q: Is there any research on Pycnogenol's role in cognitive function?

Clinical studies have been undertaken to evaluate Pycnogenol's potential role in supporting cognitive function. This research has investigated its effects on certain aspects of mental performance, including working memory, particularly in older adults.

Q: Is it normal to have dark colored urine after taking Pycnogenol?

Dark colored urine is not listed as a common or officially documented side effect of Pycnogenol. Safety reports indicate this symptom is extremely rare. While published case reports have linked it to a severe muscle condition related to non-recommended consumption, it is not a typically documented adverse event.

How should Pycnogenol be stored and disposed of?

How to Store and Dispose of Pycnogenol?

Regulatory labeling for Pycnogenol (Pine Bark Extract) formulations, including those listed as unapproved OTC products in the NIH DailyMed database, establishes specific requirements for product handling, storage, and disposal.

Storage Conditions

Requirement Official Instruction
Environment Store the product in a cool, dry place.
Container Integrity Do not use if the tamper evident seal is broken or missing.
Child Safety Keep out of reach of children.

Disposal

No product-specific disposal instructions are documented in the official regulatory labeling. Therefore, disposal of unused or expired Pycnogenol should align with general guidance from the U.S. Food and Drug Administration (FDA) for non-hazardous medicines. This guidance prioritizes using local medicine take-back programs or, if unavailable, mixing the product with an undesirable substance before discarding it in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Pycnogenol found in:

A-Z Index: